SCHEMBL13138374

SCHEMBL13138374

CCCc1nc(-c2ccc(F)cc2)[nH]c1-c1ccc(C#N)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 7/20 0.57
MAPK13 O15264 5/20 0.57
MAPK12 P53778 5/20 0.57
MAPK11 Q15759 5/20 0.57
GCGR P47871 5/20 0.57
ALOX5 P09917 3/20 0.57
RAF1 P04049 1/20 0.43
IDO1 P14902 1/20 0.41
RHEB Q15382 1/20 0.41
PRKD3 O94806 1/20 0.41
MAP4K4 O95819 1/20 0.41
FRK P42685 1/20 0.41
MAPK9 P45984 1/20 0.41
CSNK1A1 P48729 1/20 0.41
CSNK1D P48730 1/20 0.41
GSK3B P49841 1/20 0.41
PTK6 Q13882 1/20 0.41
PRKD2 Q9BZL6 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
DGAT1 O75907 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13115389 0.89 MAPK11 (0.49) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL13115282 0.88 MAPK14 (0.56) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL13115392 0.84 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL13115404 0.83 MAPK11 (0.61) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL13137171 0.81 ALOX5 (0.46) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL13115395 0.81 MAPK14 (0.58) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL13115397 0.81 ALOX5 (0.58) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL13137669 0.81 ALOX5 (0.44) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL13115410 0.80 MAPK11 (0.41) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL13115235 0.78 MAPT (0.48) MAPK14MAPK13MAPK12MAPK11GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100256165-A1 LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER HONGU MITSUYA 2010-10-07 US disclosed
US-7759373-B2 Large conductance calcium-activated K channel opener MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256165-A1 LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER KCNN3, KCNN2, KCNN1 MAPK14 1232/4885MAPK13 1596/4885MAPK12 1815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.